Choosing the right partner for your high-throughput screening (HTS) campaign leads to greatest success.
Learn how to maximize quality hits and reduce costs along the drug discovery pathway. From assay development through the final data package, you'll gain insight, and answers to the following questions:
- Should you outsource?
- Which assays are right for your target?
- When is it beneficial to miniaturize?
- What platforms are available?
- What should I ask my provider?
- David Cronk, CBiol, MSB, Director, Hit Discovery, Charles River Laboratories, Early Discovery, Chesterford Research Park, Saffron Walden, UK
- Victoria Wong, PhD, Senior Principal Scientist, Pfizer